Balyasny Asset Management LLC Incyte Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 10,200 shares of INCY stock, worth $724,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,200

Previous 5,629 81.2%

Holding current value

$724,710

Previous $341,000 97.65%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $581,096 - $695,430	10,136 Added 180.07%	15,765 $1.04 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $123,292 - $153,573	-2,409 Reduced 29.97%	5,629 $341,000
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $404,445 - $476,251	-7,152 Reduced 47.08%	8,038 $457,000
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $384,523 - $473,208	7,372 Added 94.3%	15,190 $953,000
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $21.8 Million - $24.8 Million	-376,850 Reduced 97.97%	7,818 $451,000
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $23.4 Million - $29 Million	384,668 New	384,668 $23.9 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $17.4 Million - $21.7 Million	258,323 Added 127.59%	460,793 $37 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $12.7 Million - $15.9 Million	191,673 Added 1775.24%	202,470 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $23.2 Million - $29.2 Million	-351,284 Reduced 97.02%	10,797 $820,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $46.1 Million - $55.7 Million	-698,650 Reduced 65.86%	362,081 $28.8 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $19 Million - $22.2 Million	300,092 Added 39.45%	1,060,731 $77.9 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $52.2 Million - $63.9 Million	760,639 New	760,639 $52.3 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $4.72 Million - $6.23 Million	-62,031 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $7.21 Million - $8.73 Million	-89,354 Reduced 59.02%	62,031 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $5.59 Million - $7.21 Million	65,706 Added 76.69%	151,385 $13.6 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $3.73 Million - $5.08 Million	59,041 Added 221.64%	85,679 $6.27 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $7.99 Million - $10.5 Million	-109,454 Reduced 80.43%	26,638 $2.33 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $9.38 Million - $11.3 Million	127,562 Added 1495.45%	136,092 $11.6 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $14 Million - $19.5 Million	-220,945 Reduced 96.28%	8,530 $734,000
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $6.08 Million - $7.27 Million	-103,942 Reduced 31.17%	229,475 $14.6 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $19.2 Million - $23 Million	310,189 Added 1335.41%	333,417 $23 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $5.43 Million - $7.49 Million	-89,219 Reduced 79.34%	23,228 $1.56 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $5.6 Million - $6.81 Million	-67,481 Reduced 37.5%	112,447 $9.37 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $12.2 Million - $15.2 Million	130,345 Added 262.88%	179,928 $17 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $5.41 Million - $6.86 Million	49,583	49,583 $5.79 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Incyte Corp Transaction History